(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
- CAS No.
- 219719-95-6
- Chemical Name:
- (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
- Synonyms
- Fluticasone USP RC B;Fluticasone Impurity 54;Fluticasone Propionate RC B;Fluticasone Trioxo Impurity;Fluticasone Related CoMpound B;Fluticasone USP Related Compound B;(5'R,6S,8S,9R,10S,11S,13S,14S,16R);Fluticasone Impurity 10(Fluticasone USP RC B);Fluticasone Propionate USP Related Compound B;Fluticasone Related Compound B (Fluticasone Trioxo Impurity)
- CBNumber:
- CB92694572
- Molecular Formula:
- C22H24F2O5S
- Molecular Weight:
- 438.48
- MOL File:
- 219719-95-6.mol
- Modify Date:
- 2023/4/23 13:52:06
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione Properties
Melting point | >125°C (dec.) |
---|---|
Boiling point | 562.1±60.0 °C(Predicted) |
Density | 1.43±0.1 g/cm3(Predicted) |
storage temp. | -20°C Freezer |
solubility | DMSO (Slightly), Methanol (Slightly, Sonicated) |
form | Solid |
pka | 12.93±0.70(Predicted) |
color | Off-White to Pale Beige |
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 50)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | China | 30253 | 58 | Inquiry |
sgtlifesciences pvt ltd | +8617013299288 | China | 12382 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Shenzhen Excellent Biomedical Technology Co., Ltd. | 18318671572 | China | 4993 | 58 | Inquiry |
Nanjing Shizhou Biology Technology Co.,Ltd | 025-85560043 15850508050 | China | 9287 | 58 | Inquiry |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | China | 18865 | 58 | Inquiry |
219719-95-6((6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione)Related Search:
Fluticasone
5-Chloromethyl 6a,9a-Difluoro-11-hydroxy-16a-methyl-3-oxo-17a-(propionyloxy)-androsta-1,4-diene-17-carbothioate
(6α,11β,16α,17α)-(6'α,11'β,16'α,17'α)-17,17'-(Trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-androsta-1,4-dien-3-one
DesfluoroMethyl Fluticasone Propionate Disulfide
Fluticasone IMpurity
chevron_left
1of4
chevron_right
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
Fluticasone Related CoMpound B
Fluticasone USP RC B
Fluticasone Impurity 10(Fluticasone USP RC B)
6alpha,9alpha-Difluoro-11beta-hydroxy-16alpha-methyl-2',3,4'-trioxo-17alpha-spiro(androsta-1,4-diene-17,5'-(1,3)oxathiolane)
(5R,6'S,8'S,9'R,10'S,11'S,13'S,14'S,16'R)-6',9'-difluoro-11'-hydroxy-10',13',16'-trimethylspiro[1,3-oxathiolane-5,17'-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene]-2,3',4-trione
Fluticasone USP Related Compound B/Fluticasone Trioxo Impurity/6α,9α-Difluoro-11β-hydroxy-16α-methyl-2',3,4'-trioxo-17α-spiro(androsta-1,4-diene-17,5'-(1,3)oxathiolane)
(5'R,6S,8S,9R,10S,11S,13S,14S,16R)
Fluticasone USP Related Compound B
Spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione, 6,9-difluoro-11-hydroxy-16-methyl-, (6α,11β,16α,17α)- (9CI)
Fluticasone Related Compound B (Fluticasone Trioxo Impurity)
Fluticasone Propionate RC B
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydrospiro[cyclopenta[a]phenanthrene-17,5'-[1,3]oxathiolane]-2',3,4'(6H)-trione
(6a,11β,16a,17a)-6,9-Difluoro-11-hydroxy-16-methyl-spiro[androsta-1,4-diene-17,5-[1,3]oxathiolane]-
Fluticasone Trioxo Impurity
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
Fluticasone Propionate USP Related Compound B
Spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione, 6,9-difluoro-11-hydroxy-16-methyl-, (6α,11β,16α,17α)- (9CI)
Spiro[androsta-1,4-diene-17,5′-[1,3]oxathiolane]-2′,3,4′-trione, 6,9-difluoro-11-hydroxy-16-methyl-, (6α,11β,16α,17α)-
Fluticasone Impurity 54
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-spiro[androstα-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione
219719-95-6
C22H24F2O5S
Pharmaceuticals, Intermediates & Fine Chemicals, Steroids